Could donor immune cells fight cancer? new trial tests ACIT-1 therapy.
NCT ID NCT03096093
First seen Jan 29, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This early-phase study tests a new treatment called ACIT-1, which uses immune cells from a healthy donor to help fight cancer. The main goal is to find the safest dose and see if it can boost the body's immune response against tumors. The trial includes 34 adults with pancreatic cancer or other advanced cancers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal Liverpool University Hospital
Liverpool, Merseyside, L7 8XP, United Kingdom
-
The Clatterbridge Cancer Centre NHS Foundation Trust
Bebington, Wirral, CH63 4JY, United Kingdom
Conditions
Explore the condition pages connected to this study.